• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18464 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of alpha-glucosidase in Pompe disease
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of autologous growth factors in orthopaedic surgery
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of bevacizumab in colon cancer patients
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of ceramic or metal on metal prostheses in total hip replacement
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of ceramic prosthesis in total hip replacement
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of extracorporeal shock waves in musculoskeletal disorders
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of high-intensity focused ultrasound in prostate cancer
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hip arthroscopy
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hippotherapy
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hydroxyethyl starch (HES) as plasma expander
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of intervertebral disc prostheses for spine diseases
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography (MSCT) for coronary disease
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography (MSCT) for coronary disease
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography for the assessment of liver metastases
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of music therapy in clinical practice
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of pacemakers with managed 'ventricular pacing mode'
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of plasminogen activator inhibitor 4G/5G polymorphism testing in recurrent miscarriage
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of radiofrequency ablation of liver tumors
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of real-time PCR for the monitoring of chronic myeloid leukemia patient
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of real-time PCR in acute promyelocytic leukemia patient monitoring
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of SPECT in epilepsy
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of SPECT in epilepsy
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of surgical treatments for obesity
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of synthetic graft in knee anterior cruciate ligament reconstruction
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of thalidomide for the management of sarcomas
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of the European Appropriateness Evaluation Protocol (AEP)
2013     Health Quality Ontario (HQO) Usefulness of urinary antigen testing for Legionella in the treatment of community-acquired pneumonia: a rapid review
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of varenicline in smoking cessation therapy
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of video capsule gastrointestinal endoscopy in digestive bleeding of unknown origin
2001     Agency for Healthcare Research and Quality (AHRQ) Uses of epoetin for anemia in oncology
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Using a spectral reflectance technique to measure transcutaneous bilirubin in neonates: a new device
2015     NIHR Health Services and Delivery Research programme Using clinical practice variations as a method for commissioners and clinicians to identify and prioritise opportunities for disinvestment in health care: a cross-sectional study, systematic reviews and qualitative study
2020     NIHR Health Services and Delivery Research programme Using co-production to improve patient carer and staff experiences in health care organizations: a multi-centre, mixed methods evaluation in inpatient stroke units (CREATE)
2007     Quality Improvement Scotland (NHS QIS ) Using data to improve surgical care - the surgical profiles project
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
2008     Institute of Health Economics (IHE) Using fetal fibronectin to diagnose pre-term labour
2006     Alberta Heritage Foundation for Medical Research (AHFMR) Using HTA to identify research gaps: a pilot study
2018     Center for Evidence-based Practice (CEP) Using Patient Generated Health Data in an Electronic Health Record
2000     NIHR Health Technology Assessment programme Using routine data to complement and enhance the results of randomised controlled trials
2005     Israel Center for Technology Assessment in Health Care (ICTAHC) Using the literature to forecast utilization of emerging technologies (abstract)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ustekinumab (Stelara — Janssen Inc.) indication: psoriatic arthritis
2016     HAYES, Inc. Ustekinumab (Stelara; Janssen Biotech Inc.) for treatment of psoriatic arthritis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for Crohn's disease
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for plaque psoriasis in adolescents
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for psoriatic arthritis
2010     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for psoriatic arthritis - second line after disease modifying anti-rheumatic drugs (DMARDs)
2019     European Network for Health Technology Assessment (EUnetHTA) Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response with, lost response to or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies
2009     National Institute for Health and Clinical Excellence (NICE) Ustekinumab for the treatment of adults with moderate to severe psoriasis
2009     NIHR Health Technology Assessment programme Ustekinumab for the treatment of moderate to severe psoriasis
2013     NIHR Health Technology Assessment programme Ustekinumab for treating active and progressive psoriatic arthritis
2005     Agency for Healthcare Research and Quality (AHRQ) Usual care in the management of chronic wounds: a review of the recent literature
2003     Wessex Institute for Health Research and Development (WIHRD) Uterine artery embolisation for fibroids
2003     National Institute for Clinical Excellence (NICE) Uterine artery embolisation for fibroids
2010     National Institute for Health and Clinical Excellence (NICE) Uterine artery embolisation for fibroids
2004     National Institute for Clinical Excellence (NICE) Uterine artery embolisation for the treatment of fibroids
2006     Adelaide Health Technology Assessment (AHTA) Uterine artery embolisation for the treatment of symptomatic uterine fibroids
2009     HAYES, Inc. Uterine artery embolization
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Uterine artery embolization for the management of uterine fibroids
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Uterine artery embolization for the treatment of fibroids
2005     HAYES, Inc. Uterine artery embolization for treatment of fibroids
2003     HAYES, Inc. Uterine artery embolization for treatment of fibroids
2002     Blue Cross Blue Shield Association (BCBS) Uterine artery embolization for treatment of symptomatic uterine fibroids
2003     Institute for Clinical Systems Improvement (ICSI) Uterine artery embolization for uterine fibroids
2001     ECRI Uterine fibroid embolization for the treatment of fibroids
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2002     Agency for Healthcare Research and Quality (AHRQ) Utility of blood pressure monitoring outside of the clinic setting
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of exome sequencing for diagnosed dismorphic syndromes, with or without intellectual disabilities. Literature review
2008     Agency for Healthcare Research and Quality (AHRQ) Utility of monitoring mycophenolic acid in solid organ transplant patients
2008     Agency for Healthcare Research and Quality (AHRQ) Utility of monitoring mycophenolic acid in solid organ transplant patients
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Utility of MuSK antibodies in patients with myastenia gravis
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of pulmonary metastases resection for colorectal cancer
2015     Andalusian Health Technology Assessment Area (AETSA) Utility of QF_PCR in prenatal diagnosis of fetal aneuploidies
2005     Institute for Clinical Evaluative Sciences (ICES) Utilization of CT and MRI scanning among cancer patients in Ontario, 1993-2002
2006     Medical Advisory Secretariat (MAS) Utilization of DXA bone mineral densitometry in Ontario: an evidence-based analysis
2005     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Utilization of information and communication technology in managing chronic diseases: a systematic review IPE-05/45 (Public report)
2003     Israel Center for Technology Assessment in Health Care (ICTAHC) Utilization patterns of CT and MRI in Israel
1994     Health Council of the Netherlands Gezondheidsraad (GR) UV radiation from sunlight
2008     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against cervical cancer
1991     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against Haemophilus influenzae type b
2009     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pandemic influenza A/H1N1 2009: target groups and prioritisation
2004     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pertussis
2015     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pertussis: aims and strategy
2003     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of children against hepatitis B
2013     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of infants against pneumococcal infections (3)
2011     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of young children against tuberculosis
2000     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination policies in case of an influenza pandemic
2010     NIHR Health Technology Assessment programme Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccine for herpes simplex
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccine for herpes zoster
2012     Belgian Health Care Knowledge Centre (KCE) Vaccine safety surveillance in Belgium : place and limits of a background rate approach
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for avian influenza
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for HIV
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for metastatic hormone-refractory prostate cancer
2015     NIHR Health Technology Assessment programme Vaccines for preventing influenza in healthy adults (A060)
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for prevention of human papillomavirus infection
2003     Quality Improvement Scotland (NHS QIS ) Vacuum assisted closure (VAC) for wound healing
2004     Medical Advisory Secretariat (MAS) Vacuum assisted closure therapy for wound care
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vacuum assisted wound closure therapy